Effects of Helicobacter pylori eradication on proteinuria: A prospective study

Wiener Klinische Wochenschrift

Volumn 124, Issue 7-8, 2012, Pages 241-244

  Aydogan, Timucin ^a   Ulas, Turgay ^a   Selcoki, Yusuf ^b   Alkan, Rabia ^c   Yılmaz, Omer Caglar ^b   Yalcın, Kadir Serkan ^b   Inan, Osman ^b   Dal, Mehmet Sinan ^d   Turkay, Cansel ^b  

^a HARRAN UNIVERSITY   (Turkey)

^b FATIH UNIVERSITY   (Turkey)

^c Mus State Hospital   (Turkey)

^d DICLE UNIVERSITY   (Turkey)

Author keywords

Helicobacter pylori; Immune response; Infections; Proteinuria; Treatment

Indexed keywords

AMOXICILLIN; BISMUTH CITRATE; CLARITHROMYCIN; CREATININE; LANSOPRAZOLE; PROTEIN;

ADULT; ARTICLE; CONTROLLED STUDY; ENDOSCOPY; ERADICATION THERAPY; FEMALE; HELICOBACTER INFECTION; HUMAN; MAJOR CLINICAL STUDY; MALE; PROSPECTIVE STUDY; PROTEIN URINE LEVEL; PROTEINURIA; TREATMENT DURATION; TREATMENT RESPONSE; URINALYSIS;

EID: 84863722888     PISSN: 00435325     EISSN: 16137671     Source Type: Journal    
DOI: 10.1007/s00508-012-0150-0     Document Type: Article

References (12)

1. Kanbay M, Kanbay A, Boyacioglu S. Helicobacter pylori infection as a possible risk factor for respiratory system disease: a review of the literature. Respir Med. 2007;101(2):203-9. (Pubitemid 46075962)
2. Oshima T, Ozono R, Yano Y, Oishi Y, Teragawa H, Higashi Y, et al. Association of Helicobacter pylori infection with systemic inflammation and endothelial dysfunction in healthy male subjects. J Am Coll Cardiol. 2005;45(8):1219-22. (Pubitemid 40523140)
3. Franceschi F, Gasbarrini A. Helicobacter pylori and extra-gastric diseases. Best Pract Res Clin Gastroenterol. 2007;21(2):325-34.
4. Bodger K, Crabtree JE. Helicobacter pylori and gastric inflammation. Br Med Bull. 1998;54(1):139-50. (Pubitemid 28105322)
5. Konturek SJ, Konturek PC, Pieniazek P, Bielański W. Role of Helicobacter pylori infection in extragastroduodenal disorders: introductory remarks. J Physiol Pharmacol. 1999;50(5):683-94. (Pubitemid 30090004)
6. Bohr UR, Annibale B, Franceschi F, Roccarina D, Gasbarrini A. Extragastric manifestations of Helicobacter pylori infection-other Helicobacters. Helicobacter. 2007;12(Suppl 1):45-53. (Pubitemid 47312377)
7. Kanbay M, Kasapoglu B, Akcay A. An occult risk factor for proteinuria: Helicobacter pylori infection. Med Hypotheses. 2007;69(3):709-10. (Pubitemid 47043246)
8. Nagashima R, Maeda K, Yuda F, Kudo K, Saitoh M, Takahashi T. Helicobacter pylori antigen in the glomeruli of patients with membranous nephropathy. Virchows Arch. 1997;431(4):235-9. (Pubitemid 27470620)
9. Moriyama T, Kaneko T, Fujii M, Tsubakihara Y, Kawano S, Imai E. High prevalence of Helicobacter pylori infection in Japanese patients with membranous nephropathy. Aliment Pharmacol Ther. 2006;2(1):189-93
10. Sugimoto T, Furukawa T, Maeda T, Somura M, Uzu T, Kashiwagi A. Marked reduction of proteinuria after eradication of gastric Helicobacter pylori infection in a patient with membranous nephropathy: coincidental or associated? Intern Med. 2007;46(17):1483-4. (Pubitemid 47455779)
11. Hirschl AM. Helicobacter pylori: pathogens, pathomechanisms and epidemiology. Wien Klin Wochenschr. 1994;106(17):538-42. (Pubitemid 24293267)
12. Kanbay M, Kasapoglu B, Turgut F, Uz E, Bavbek N, Akcay A. Helicobacter pylori: a major risk factor for endothelial dysfunction? Med Hypotheses. 2007;69(1):227-8. (Pubitemid 46686965)